Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Jan, 10.1007/s11523-022-00941-7, 2023)

导出原文传递

翻译打印收藏纠错

作者： Popat, Sanjay ^[1] ; Ahn, Myung-Ju ^[2] ; Ekman, Simon ^[3] ; Leighl, Natasha B. ^[4] ; Ramalingam, Suresh S. ^[5] ; Reungwetwattana, Thanyanan ^[6] ; Siva, Shankar ^[7] ; Tsuboi, Masahiro ^[8] ; Wu, Yi-Long ^[9] ; Yang, James Chih-Hsin

作者单位： Royal Marsden NHS Foundation Trust,Royal Marsden Hosp ^[1] Samsung Med Ctr,Sungkyunkwan Univ ^[2] Thorac Oncol Ctr,Karolinska Univ Hosp ^[3] Med Oncol,Princess Margaret Canc Ctr ^[4] Winship Canc Inst,Emory Univ ^[5] Fac Med Ramathibodi Hosp,Mahidol Univ ^[6] Dept Radiat Oncol,Peter MacCallum Canc Ctr ^[7] Dept Thorac Surg & Oncol,Natl Canc Ctr Hosp East ^[8] Guangdong Lung Canc Inst,Guangdong Prov Peoples Hosp ^[9]

发布时间 2023-09-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Targeted oncology

2023年18卷2期

311-311页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Jan, 10.1007/s11523-022-00941-7, 2023)

Targeted oncology

相似文献

Targeted oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Jan, 10.1007/s11523-022-00941-7, 2023)

Targeted oncology

相似文献

Targeted oncology

相关期刊

检索历史清除